| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A better way to monitor warfarin therapy?
|
Witt, Daniel M.
|
|
|
137 |
20 |
p. 2713-2714
|
article
|
| 2 |
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas
|
Reimann, Maurice
|
|
|
137 |
20 |
p. 2785-2799
|
article
|
| 3 |
A new wrinkle for skin dendritic cell migration
|
Cook, Donald N.
|
|
|
137 |
20 |
p. 2716-2717
|
article
|
| 4 |
Badat M, Davies JOJ, Fisher CA, et al. A remarkable case of HbH disease illustrates the relative contributions of the α-globin enhancers to gene expression. Blood. 2021;137(4):572-575.
|
|
|
|
137 |
20 |
p. 2854
|
article
|
| 5 |
Basophilic myeloblasts: a clue for CML blast phase
|
Liu, Huifei
|
|
|
137 |
20 |
p. 2852
|
article
|
| 6 |
Coexistence of BCR-ABL1 and RUNX1-RUNX1T1 in a de novo AML
|
Musani, Rumina
|
|
|
137 |
20 |
p. 2853
|
article
|
| 7 |
CXCR4 signaling controls dendritic cell location and activation at steady state and in inflammation
|
Gallego, Carmen
|
|
|
137 |
20 |
p. 2770-2784
|
article
|
| 8 |
Editorial Board
|
|
|
|
137 |
20 |
p. i
|
article
|
| 9 |
Embryonic MK activation: a delicate balance
|
Sola-Visner, Martha
|
|
|
137 |
20 |
p. 2714-2715
|
article
|
| 10 |
Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia
|
Klintman, Jenny
|
|
|
137 |
20 |
p. 2800-2816
|
article
|
| 11 |
Heightened activation of embryonic megakaryocytes causes aneurysms in the developing brain of mice lacking podoplanin
|
Hoover, Christopher
|
|
|
137 |
20 |
p. 2756-2769
|
article
|
| 12 |
How I treat primary ITP in adult patients who are unresponsive to or dependent on corticosteroid treatment
|
Ghanima, Waleed
|
|
|
137 |
20 |
p. 2736-2744
|
article
|
| 13 |
Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study
|
Oskarsdottir, Alma R.
|
|
|
137 |
20 |
p. 2745-2755
|
article
|
| 14 |
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias
|
Thijssen, Rachel
|
|
|
137 |
20 |
p. 2721-2735
|
article
|
| 15 |
Kinase inhibitors in CLL: drawing the roadmap
|
Fowler, Nathan
|
|
|
137 |
20 |
p. 2717-2719
|
article
|
| 16 |
Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy
|
Mato, Anthony R.
|
|
|
137 |
20 |
p. 2817-2826
|
article
|
| 17 |
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry
|
Giannis, Dimitrios
|
|
|
137 |
20 |
p. 2838-2847
|
article
|
| 18 |
Primary therapy and survival in patients with Burkitt lymphoma in The Netherlands: a population-based study, 1989-2018
|
Issa, D.E.
|
|
|
137 |
20 |
p. 2848-2851
|
article
|
| 19 |
Prognosis of comutations in IDH1/2-mutated AML
|
|
|
|
137 |
20 |
p. 2856
|
article
|
| 20 |
Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study
|
Duchmann, Matthieu
|
|
|
137 |
20 |
p. 2827-2837
|
article
|
| 21 |
Shah NN, Ahn KW, Litovich C, et al. Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era? Blood. 2021;137(10):1416-1423.
|
|
|
|
137 |
20 |
p. 2854-2855
|
article
|
| 22 |
Targeting MCL-1 and BCL-2: a 1-2 punch
|
Brown, Jennifer R.
|
|
|
137 |
20 |
p. 2711-2712
|
article
|
| 23 |
What can Heraclitus tell us about AML?
|
Ganser, Arnold
|
|
|
137 |
20 |
p. 2719-2720
|
article
|
Journal description